EPB154 Doravirine associated resistance mutations in antiretroviral therapy naïve and experienced HIV-1C infected people in BotswanaE-posterART in highly treatment-experienced persons
PEMOF31 Dos and don'ts for community-led HIV programming in challenging contexts in Eastern Europe and Central Asia: lessons learned for funders and implementersPoster exhibitionInvesting in regional HIV programmes and regional key population movements
OAD0405 DOTS PLUS: a promising approach to increasing adherence to tuberculosis, drug resistant tuberculosis and antiretroviral HIV treatment in MozambiqueOral abstract session with live Q&ALiving with HIV and co-infections and/or co-morbidities
OALBX0103 Doxycycline post-exposure prophylaxis for STI prevention among MSM and transgender women on HIV PrEP or living with HIV: high efficacy to reduce incident STI's in a randomized trialOral abstract session with live Q&ASTIs (including HPV)
EPE116 DREAMS cascade in Botswana: findings and lessons learnedE-posterImplementation of HIV status-neutral approach to enhance HIV testing, HIV prevention and HIV treatment services
EPE260 Drone technology to facilitate access to medical supplies and commodities for maternal, child and HIV treatment in East and Southern Africa RegionE-posterApproaches to supporting resilient health systems
EPF044 Drug decriminalization done right: a civil society platformE-posterCriminalization, incarceration and living in closed settings
EPF072 Drug enforcement remains a top barrier for people who inject drugs to access HIV and TB prevention, care, and treatment in Georgia, Kyrgyzstan, Moldova, Russia, Tajikistan, Ukraine, and UzbekistanE-posterHuman rights of people living with HIV and key populations
EPB244 Drug resistance in children with HIV in the Democratic Republic of Congo, Equatorial Guinea and PanamaE-posterResistance to ART
EPB178 Drug-drug interactions between antiretrovirals and remdesivirE-posterDrug interactions
621 - 630 of 2485 items